1/1
MDA + IRS trial in Katakwi, Uganda
Download all (13.23 MB) This item is shared privately
dataset
modified on 2022-03-31, 13:33 These datasets are from the prospective controlled community trial described in "Impact of population based indoor residual spraying with and without the mass drug administration with dihydroartemisinin-piperaquine on malaria prevalence in a high transmission setting: a controlled trial in northeastern Uganda," submitted for review to Malaria Journal.
Datasets shared here include: (a) CompleteEnumerationR1toR4: De-identified enumeration dataset of all subjects enrolled in the open cohort of this prospective controlled community trial from Q4 2016 to Q2 2019; (b) MDACoverageR1toR4: 4 rounds of MDA coverage data; and (c) Surveys1to6_Mar2022: malaria prevalence and LLIN data for all 6 cross-sectional population surveys from November 2016 to April 2019.
Funding
To drive down malaria prevalence in two communities in a high transmission area, and maintain it at a low level, using novel sequences of currently available control interventions
Bill & Melinda Gates Foundation
Find out more...